Our gastroenterology and hepatology advances
As leaders in pediatric gastroenterology and hepatology research, our researchers make discoveries and disseminate this knowledge across the globe to transform pediatric care.
At the Digestive Health Institute, our highly specialized teams have transformed treatments and increased understanding of various gastrointestinal and hepatological conditions, including:
- Inflammatory bowel diseases (IBD)
- Eosinophilic gastrointestinal diseases (EGIDs)
- Celiac disease
- Intestinal failure
- Pediatric liver diseases
Advances in gastroenterology and digestive health
Through new tests, therapies and scientific evidence, we are improving care for children with digestive disease.
Most recently, Joel Friedlander, MD, and his partners formed Triple Endoscopy Inc. to develop what they call a turnkey kit for hospitals: a scope, virtual reality goggles to entertain patients during endoscopies, and the software system that ties those pieces together. This kit is on track to hit the market later this year.
Other significant gastroenterology advances from our Digestive Health Institute include:
Advances in hepatology research
Our developments in the field of pediatric hepatology include:
- Evidence demonstrating that sleep-disordered breathing is an important trigger in the progression of pediatric non-alcoholic fatty liver disease to non-alcoholic steatohepatitis
- New findings demonstrating the role of B cells in the onset and progression of biliary atresia
- Defining the factors that determine long-term outcomes after pediatric liver transplantation
Ongoing research at the Digestive Health Institute
Led by Ronald Sokol, MD, one of the top-funded pediatric researchers in the country, our Institute seeks to continually improve diagnosis, treatment and outcomes for children with digestive health issues.
Ongoing pediatric gastroenterology and digestive health research
- Studying the effect of a gluten-free diet on a variety of physical and emotional parameters
- Developing new therapies for IBD, including exploring cannabis therapy
- Establishing new therapies and national guidelines for evaluating and treating children with EGIDs
- Enhancing care for aerodigestive patients, including evaluating the impacts of procedural testing, improving the flow of the operating room for multidisciplinary procedures and developing new and safer endoscopic techniques
- Understanding how intestinal ganglion cells can be replenished in inflammatory and congenital diseases that affect gastrointestinal motility
Ongoing pediatric hepatology research
As participants and leaders of the Childhood Liver Disease Research and Education Network (ChiLDREN), our hepatology researchers aim to better understand the etiology and outcomes of rare pediatric liver diseases, develop predictive tools and personalize and test new therapies. Some of our hepatology research includes:
- Studying the cause and new therapies for nonalcoholic fatty liver disease (NAFLD), the most common liver disease in children and adults
- Exploring clues to the causes of biliary atresia and parenteral nutrition-associated liver disease (PNALD), pathways of disease progression and potential therapeutic approaches
- Determining genetic and epigenetic factors that are essential to the formation of bile in the developing infant liver and during illness
- Trialing new therapies for Hepatitis B and C viruses, leading to new cures and treatments of these viruses in children
- Identifying children who develop tolerance to the transplanted liver and can be taken off of immunosuppressive therapy
What our gastroenterology and hepatology research means for kids
Our team is committed to improving the lives of children with digestive conditions. That's why we are working to develop minimally invasive tests and procedures that are faster, safer, more affordable and more convenient for patients. We're also developing treatments and cures for some of the most serious diseases of the digestive system.
Through cutting-edge research, we are helping children throughout the United States. Our contributions have helped to establish clinical pathways and national guidelines on button battery ingestions, adverse events following endoscopy and more.
Contact us at 720-777-6669.